TENON MEDICAL, INC. Financials Tenon Medical, Inc.
Equities
TNON
US88066N2045
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6987 USD | -0.89% |
|
-5.99% | -55.78% |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Capitalization 1 | 17.75 | 3.904 | 2.627 | - |
| Enterprise Value (EV) 1 | 17.75 | 3.904 | -3.333 | -7.085 |
| P/E ratio | -0.67 x | -0.18 x | -0.17 x | -0.38 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 25.7 x | 1.33 x | 0.58 x | 0.29 x |
| EV / Revenue | 25.7 x | 1.33 x | -0.73 x | -0.79 x |
| EV / EBITDA | - | - | - | - |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Price to Book | - | - | - | - |
| Nbr of stocks (in thousands) | 1,124 | 2,471 | 3,727 | - |
| Reference price 2 | 15.80 | 1.580 | 0.7050 | 0.7050 |
| Announcement Date | 09/03/23 | 12/03/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net sales 1 | 0.1598 | 0.691 | 2.928 | 4.546 | 8.992 |
| EBITDA | - | - | - | - | - |
| EBIT 1 | - | -18.72 | -15.73 | -14.53 | -13.47 |
| Operating Margin | - | -2,709.84% | -537.12% | -319.6% | -149.75% |
| Earnings before Tax (EBT) 1 | - | -18.92 | -15.58 | -13.64 | -12.69 |
| Net income 1 | -7.048 | -18.92 | -15.58 | -14.6 | -13.5 |
| Net margin | -4,410.76% | -2,737.63% | -532.14% | -321.14% | -150.1% |
| EPS 2 | - | -23.60 | -8.590 | -4.140 | -1.850 |
| Free Cash Flow | - | - | - | - | - |
| FCF margin | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 14/03/22 | 09/03/23 | 12/03/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 0.135 | 0.208 | 0.277 | 0.433 | 0.743 | 0.944 | 0.808 | 0.719 | 0.9095 | 1.29 | 1.628 | 1.719 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | -5.456 | -3.262 | -7.928 | -4.886 | -4.322 | -3.378 | -3.1 | -3.506 | -3.572 | -3.681 | -3.77 | -3.384 |
| Operating Margin | -4,041.48% | -1,568.27% | -2,862.09% | -1,128.41% | -581.7% | -357.84% | -383.66% | -487.62% | -392.74% | -285.46% | -231.54% | -196.86% |
| Earnings before Tax (EBT) 1 | -5.488 | -3.171 | -7.905 | -4.83 | -4.285 | -3.332 | -3.1 | -3.576 | -3.412 | -3.362 | -3.29 | -3.384 |
| Net income 1 | -5.488 | -3.171 | -7.905 | -4.83 | -4.285 | -3.332 | -3.1 | -3.576 | -3.572 | -3.681 | -3.77 | -3.384 |
| Net margin | -4,065.19% | -1,524.52% | -2,853.79% | -1,115.47% | -576.72% | -352.97% | -383.66% | -497.36% | -392.74% | -285.46% | -231.54% | -196.86% |
| EPS 2 | -4.884 | -2.800 | -7.000 | -4.300 | -3.300 | -1.460 | -0.6800 | -1.250 | -1.085 | -0.9900 | -0.9250 | -1.190 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/08/22 | 10/11/22 | 09/03/23 | 09/05/23 | 08/08/23 | 14/11/23 | 12/03/24 | 14/05/24 | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - |
| Net Cash position 1 | - | - | - | 5.96 | 9.71 |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - |
| Capex 1 | - | 0.85 | - | 0.49 | 0.4 |
| Capex / Sales | - | 122.58% | - | 10.87% | 4.45% |
| Announcement Date | 14/03/22 | 09/03/23 | 12/03/24 | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.705
USD
Average target price
3.5
USD
Spread / Average Target
+396.49%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -55.78% | 2.63M | |
| +14.21% | 129B | |
| -7.72% | 10.98B | |
| -1.95% | 8.22B | |
| +40.43% | 5.76B | |
| -27.04% | 4.41B | |
| +7.47% | 3.41B | |
| -15.26% | 2.7B | |
| -12.01% | 2.1B | |
| -13.56% | 1.91B |
- Stock Market
- Equities
- TNON Stock
- Financials Tenon Medical, Inc.
